[421]
(more) PEPPER COMPONENT HOT ENOUGH TO TRIGGER SUICIDE IN PROSTATE ...
[96,0 KB]
From [csmc.edu] Last viewed: 10.07.2006
[422]
Exploring Spatial Clusters and Outliers in Prostate Cancer Rates
[377,5 KB]
From [www.sal.uiuc.edu] Last viewed: 10.07.2006
[423]
Prostate Cancer
[654,7 KB]
From [www.cancer.gov] Last viewed: 10.07.2006
[424]
Prostate Cancer Snapshot.indd
[1707,9 KB]
From [planning.cancer.gov] Last viewed: 10.07.2006
[425]
Early Prostate Cancer: Questions and Answers
[39,2 KB]
From [www.nci.nih.gov] Last viewed: 10.07.2006
[426]
Radiation Therapy for Prostate Cancer
[306,7 KB]
From [www.nlm.nih.gov] Last viewed: 10.07.2006
[427]
Antibody-Dendrimer Conjugates for Targeted Prostate Cancer Therapy
[122,2 KB]
From [nano.med.umich.edu] Last viewed: 10.07.2006
[428]
Mortality rate from early prostate cancer increased 3-fold after ...
[91,9 KB]
From [www.med.umich.edu] Last viewed: 10.07.2006
[429]
Can Men with Prostate Cancer Manage the Disease through Diet and ...
[96,1 KB]
From [www.prostateawarenessfoundation.org] Last viewed: 10.07.2006
[430]
NCI Cooperative Prostate Cancer Tissue Resource - Short Form ...
[14,4 KB]
From [cpctr.cancer.gov] Last viewed: 10.07.2006
[431]
What is Prostate Cancer?
[171,2 KB]
From [www.nlm.nih.gov] Last viewed: 10.07.2006
[432]
Use of Agricultural Pesticides and Prostate Cancer Risk in the ...
[146,9 KB]
From [dceg.cancer.gov] Last viewed: 10.07.2006
[433]
Re: Zinc Supplement Use and Risk of Prostate Cancer RN
[36,7 KB]
From [dceg.cancer.gov] Last viewed: 10.07.2006
[434]
Defeating Prostate Cancer:
[3006,4 KB]
From [planning.cancer.gov] Last viewed: 10.07.2006
[435]
Understanding Treatment Choices for Prostate Cancer
[10,4 KB]
From [www.nci.nih.gov] Last viewed: 10.07.2006
[436]
No association between green tea and prostate cancer risk in ...
[11,4 KB]
From [www.nature.com] Last viewed: 10.07.2006
[437]
Characterization of Epidemiology Data Relating to Prostate Cancer ...
From [www.epa.gov] Last viewed: 10.07.2006
[438]
THE NCRI’s SOUTH OF ENGLAND PROSTATE CANCER RESEARCH COLLABORATIVE
[25,6 KB]
From [www.icr.ac.uk] Last viewed: 06.07.2006
prostate
cancer
1146
THE NCRI’s SOUTH OF ENGLAND PROSTATE CANCER RESEARCH COLLABORATIVE
CALL FOR PROPOSALS
The National Cancer Research Institute’s (NCRI’s) South of England Prostate Cancer Research Collaborative is inviting bids for pilot and development awards. The aim of the Collaborative, which is jointly funded by the MRC, Cancer Research UK and Department of Health, is to set up research in three broad translational research areas: (A) Molecular Pathology of Prostate Cancer ; (B) Novel Therapies for Prostate Cancer ; and (C) Aetiology of Prostate Cancer . Successful applications would be expected, where appropriate, to link to these initiatives and direct their research towards the overall aims of improving the treatment of this disease and increasing the understanding of its mechanism of development.
The awards ...
[439]
Prostate Cancer:
[143,7 KB]
From [www.icr.ac.uk] Last viewed: 06.07.2006
CANCER BIOLOGY/RADIOTHERAPY
Why is prostate cancer
different?
Prostate cancer poses a unique set of challenges for the
laboratory scientist and clinician.As a result of prostate
specific antigen (PSA) testing, prostate cancer has now
become the most commonly diagnosed male cancer in the
western world with over 27,000 cases recorded annually
in the UK. It remains a major cause of mortality with
nearly 10,000 cancer deaths per year.Yet, paradoxically
most of the early prostate cancer now diagnosed by
PSA testing may not need treating at all.The rate of
progression is frequently so slow that the disease is of
no threat – indeed autopsy studies show microfocal
invasive disease in about 80% of 80-year-old men.
There is a pressing
need to understand
the processes that lead
to disease progression
in prostate cancer and
to determine the
...
[440]
Researchers Identify Molecular Cause of Drug-Resistant Prostate Cancer
[148,0 KB]
From [www.hhmi.org] Last viewed: 06.07.2006
DECEMBER 21, 2003
Researchers Identify Molecular Cause
of Drug-Resistant Prostate Cancer
Howard Hughes Medical Institute (HHMI) researchers have discovered a
surprisingly straightforward mechanism that causes prostate cancer cells to
develop resistance to cancer -fighting drugs. The studies also point to specific
ways to improve drugs to prevent the problem of drug resistance in prostate
tumors.
The researchers describe the molecular mechanism of resistance to
anti-androgen therapy for prostate cancer in an advance online publication in
the December 21, 2003, issue of the journal Nature Medicine .
"While drug therapy works in almost everyone
for a period of time ? usually measured in
years ? it stops working, despite the fact that
patients continue to take the drugs."
-- Charles L. Sawyers
HHMI investigator Charles L. Sawyers at the Jonsson Comprehensive Cancer ...
[441]
WHAT WORKS & WHAT DOESN’T WORK WITH PROSTATE CANCER
[105,9 KB]
From [www.cpcn.org] Last viewed: 06.07.2006
Tuesday 11
th
July 7:30pm
Foothills Hospital Auditorium
Come and join us at this Prostaid Calgary meeting to hear Dr. Mark Moyad,
University of Michigan who will speak on lifestyle changes, dietary supplements
and what works and doesn’t work when dealing with prostate cancer . This will be
a DVD presentation, originally given by Dr. Moyad at the Canadian Prostate
Cancer Network national conference.
There is no charge to attend any Prostaid meeting, held on the second Tuesday
of every month, at Foothills Hospital Auditorium. No tickets and no reservations
required. Light refreshments will be served.
Men with prostate cancer , their partners, families and friends are all most
welcome to attend. There will be time to ask questions and an opportunity to
meet and talk with others on the journey with prostate cancer .
Any questions? Call Bob at (403) 253-1911 ...
[442]
Prostate Cancer
[422,6 KB]
From [www.ehealthconnection.com] Last viewed: 06.07.2006
WWW.STMARYSHEALTH.COM
Understanding risk factors and treatments
INSIGHTS INTO
FEATURED SPEAKERS
Charles Reynolds, M.D.
Urology Consultants of Knoxville
Board Certified Urologist
Srinivas Boppana, M.D.
St. Mary’s Cancer Center
Board Certified Radiation Oncologist
Prostate Cancer
EDUCATIONAL PROGRAM AND SCREENINGS
Men age 45 and older are at risk for prostate cancer , and the risk increases with age.
Join us to learn about risks, symptoms and the latest treatments.
In addition to education, PSA ( Prostate Specific Antigen) testing will be offered.
This blood test is one effective way to detect prostate cancer .
Screenings will be conducted prior to program, 10:30 a.m. - 11:30 a.m
Thursday, June 29, 2006
11:30 a.m. - 1:00 p.m.
The University Club
Neyland Drive & Kingston Pike
Cost is $10.00. ...
[443]
SOS - Prostate Cancer
[262,0 KB]
From [www.cancer.org] Last viewed: 06.07.2006
A systematic
review of
prostate
cancer biopsy
schemes
Prostate Cancer
Biopsy Schemes
¦
Prostate cancer is the second leading cause
of male cancer death in Europe and North
America.
¦
Generally, men with raised PSA levels or
abnormal rectal digital examination undergo
ultrasound guided transrectal needle biopsy to
obtain samples of prostate for diagnosis.
¦
The sextant biopsy scheme has been standard
for many years, however a number of more
extended prostate biopsy schemes are now
being used in practice.
¦
The sextant scheme showed a significantly
lower cancer yield than most of the more
extensive biopsy schemes.
¦
The addition of laterally directed cores from
the lateral peripheral zone to the mid lobe
peripheral zone increases ...
[444]
National Prostate Cancer Awareness Month, 2005
[44,4 KB]
From [a257.g.akamaitech.net] Last viewed: 06.07.2006
101
Proclamations
Proc. 7920
ovarian cancer cases are diagnosed at an advanced stage, however, because
no reliable screening test exists for the disease. Because the early signs of
ovarian cancer are easy to miss and often resemble the signs of other condi-
tions, it is important for women to talk with their doctors about detection
and be aware of the risk factors and symptoms of this cancer .
There is more we need to learn about how best to prevent, detect, and treat
ovarian cancer . The National Cancer Institute (NCI) is currently sponsoring
a study on genetic and environmental factors that may increase the risk of
ovarian cancer . In addition, the NCI is sponsoring clinical trials to explore
new ways to screen for and detect ovarian cancer . Researchers are studying
new treatment options, including biological therapies, anticancer drugs,
vaccines, and other therapies to treat ...
[445]
B for “ Overcoming the Psychological (and Sexual) Side Effects of ...
[24,1 KB]
From [www.prostaid.org] Last viewed: 06.07.2006
1
B
IBLIOGRAPHY
for
“ Overcoming the Psychological (and Sexual) Side Effects
of Prostate Cancer Treatments ”
PROST AID CALGARYLecture 2006
Note: This is NOT a definitive list on the various topics covered in this lecture. Rather I have
focused here on papers from the last three years (older studies are cited therein). Many of the
papers in one sub-section below could be equally well listed in another. The half dozen papers
that I consider most important as background to my talk are in bold.
Most of these papers can be found in medical libraries. The abstracts for the majority can be
accessed for free through PubMed: (http://www.ncbi.nih.gov/entrez/query.fcgi).
O
N THE COGNITIVE EFFECTS OF ESTROGENS AND TESTOSTERONE
Beer, T.M., Bland, L.B., Bussiere, J.R., Neiss, M.B., Wersinger, E.M., Garzotto, M., Ryan, C.W., &
Janowsky, J.S. 2006. ...
[446]
MAJOR GENETIC RISK FACTOR FOR PROSTATE CANCER DISCOVERED
[133,7 KB]
From [www.cancer.northwestern.edu] Last viewed: 06.07.2006
676 N
ORTH
S
T
. C
LAIR
, S
UITE
1200
C
HICAGO
, I
LLINOIS
60611-3013
(312) 695-1304
For immediate release:
May 8, 2006
For more information, contact:
Elizabeth Crown at (312) 503-8928 or at e-crown@northwestern.edu
Broadcast Media: Tamara Kerrill Field at (847) 491-4888 or tlk@northwestern.edu
MAJOR GENETIC RISK FACTOR FOR PROSTATE CANCER
DISCOVERED
CHICAGO
---
Scientists from The Robert H. Lurie Comprehensive Cancer Center of Northwestern
University participated in a discovery of a common genetic variant that predisposes men to prostate cancer .
The gene discovery is described in a study in the online edition of Nature Genetics and will appear in the
journal’s June print edition.
The gene variant was discovered by the deCODE genetics ...
[447]
HTA Update on Prostate Cancer
[86,2 KB]
From [www.hta.ac.uk] Last viewed: 06.07.2006
The NCCHTA manages the HTA programme under contract from the Department of Health’s Research and Development Division.
web: www.ncchta.org NHSweb: nww.hta.nhsweb.nhs.uk
Cancer a Government priority
Cancer is a Government priority. Research
is a major theme within the National
Cancer Plan, which, amongst other things,
set out plans for the National Cancer
Research Network and the National Cancer
Research Institute (NCRI). Within this
framework, the NHS Plan is to increase by
£1 million the resources devoted to prostate
cancer research for each of the subsequent
three years. (The NHS Prostate Cancer
Programme website has more detail)
The DH Portfolio Director for Cancer
Research, Dr Russell Hamilton, is ensuring
that these increased investments go towards
research of greatest benefit to patients. The
NHS HTA Programme has been a major
contributor towards ...
[448]
HORMONAL THERAPY FOR PROSTATE CANCER: CLINICAL AND EXPERIMENTAL ...
[147,2 KB]
From [www.worldscibooks.com] Last viewed: 06.07.2006
1
HORMONAL THERAPY FOR PROSTATE CANCER :
CLINICAL AND EXPERIMENTAL EVIDENCE
Hiroshi Miyamoto and Chawnshang Chang
Departments of Pathology & Laboratory Medicine and Urology
University of Rochester Medical Center
Rochester, New York, USA
Introduction
The role and mechanism of androgen function have been studied in a variety
of androgen target organs, including the prostate . As is the case with normal
prostate development, the growth of prostatic neoplasms is generally
dependent on androgens, especially on 5 -dihydrotestosterone (DHT). Since
1941 when Huggins and Hodges
1
published their Nobel Prize-winning
study on the effects of hormone manipulation in patients with metastatic
prostate cancer (PCa), hormonal therapy remains the critical therapeutic
option for advanced disease. Multiple strategies have been used to reduce
serum levels of ...
[449]
(more) PEPPER COMPONENT HOT ENOUGH TO TRIGGER SUICIDE IN PROSTATE ...
[96,0 KB]
From [www.cshs.org] Last viewed: 06.07.2006
(more)
Media Contact: Cynthia Harding
Telephone: 310-423-4768
E-mail: Cynthia.harding@cshs.org
PEPPER COMPONENT HOT ENOUGH TO TRIGGER SUICIDE IN PROSTATE CANCER CELLS
LOS ANGELES (MARCH 15, 2006) – Capsaicin, the stuff that turns up the heat in jalapeños, not only
causes the tongue to burn, it also drives prostate cancer cells to kill themselves, according to studies published
in the March 15 issue of Cancer Research.
According to a team of researchers from the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai
Medical Center, in collaboration with colleagues from UCLA, the pepper component caused human prostate
cancer cells to undergo programmed cell death or apoptosis.
Capsaicin induced approximately 80 percent of prostate cancer cells growing in mice to follow the molecular
pathways leading to apoptosis. Prostate cancer tumors treated with capsaicin were ...
[450]
PROSTATE CANCER: Signature of a partnership agreement between ...
[328,1 KB]
From [www.ipsen.com] Last viewed: 06.07.2006
1/2
PROSTATE CANCER :
Signature of a partnership agreement
between Beaufour Ipsen and UroGene
Paris and Evry-Genopole, FRANCE – July 17, 2002 – The pharmaceutical group
Beaufour Ipsen and the biopharmaceutical company UroGene have just signed a
partnership agreement for the functional and clinical evaluation of a class of molecules in
the field of prostate cancer .
UroGene will be contributing its molecular genomic know-how, its biological and clinical
expertise, and its biological resources and data base, in order to implement this
programme.
"This agreement is very pertinent to the Beaufour Ipsen Group strategy since oncology is
one of our major lines of therapeutic research. This agreement with UroGene regarding
an important medical application is very satisfactory" stated Christophe Thurieau,
Director of Research of the Henri Beaufour Institute. "We are convinced that evaluating ...
Found 2058 documents
Page 15 of 69 Pages:
<< < 10 11 12 13 14 15 16 17 18 19 20 > >>
cancers
homepage
last week